Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

1.8K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.8K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

824
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
824
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

768
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future Directions of the National Prostate Cancer Audit.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Flu-based and PD1-based vaccines for SARS-CoV-2: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Rat hepatitis E virus and genotype 4 hepatitis E virus infections among immunocompromised persons and patients with hepatitis in Hong Kong: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Air dispersal of multi-drug-resistant organisms including meticillin-resistant Staphylococcus aureus, carbapenem-resistant Acinetobacter baumannii and carbapenemase-producing Enterobacterales in general wards: surveillance culture of air grilles.

The Journal of hospital infection·2024
Same author

Single amino acid substitution and inter-species transmission of MERS-coronavirus from camels to humans: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024

Related Experiment Video

Updated: May 5, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.3K

Severe acute respiratory syndrome.

J S M Peiris1, Y Guan, K Y Yuen

  • 1Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Pokfualm, Hong Kong Special Administrative Region of China. malik@hkucc.hku.hk

Nature Medicine
|December 4, 2004
PubMed
Summary

Severe acute respiratory syndrome (SARS) emerged from an animal coronavirus, rapidly spreading globally via human transmission. Scientific advancements offer hope for vaccines and therapies against this infectious disease.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

2.0K

Related Experiment Videos

Last Updated: May 5, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.3K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

2.0K

Area of Science:

  • * Virology and Infectious Diseases
  • * Epidemiology and Public Health

Background:

  • * Severe acute respiratory syndrome (SARS) emerged from an unrecognized animal coronavirus.
  • * 'Wet markets' in southern China facilitated viral adaptation for human transmission.
  • * Hospitals and international travel acted as amplifiers for global spread.

Purpose of the Study:

  • * To review scientific progress in understanding SARS coronavirus (SARS-CoV) and the disease.
  • * To highlight advancements in developing vaccines and therapies for SARS.

Main Methods:

  • * Comprehensive literature review of scientific publications on SARS.
  • * Analysis of epidemiological data and viral characteristics.
  • * Assessment of vaccine and therapeutic development progress.

Main Results:

  • * Significant progress has been made in understanding SARS-CoV's virology and pathogenesis.
  • * Development of potential vaccines and therapeutic strategies is advancing.
  • * The global response to SARS demonstrated effective containment strategies.

Conclusions:

  • * The SARS outbreak highlighted the importance of understanding zoonotic transmissions.
  • * Coordinated global efforts were crucial in containing the SARS epidemic.
  • * The SARS response established a new model for managing future infectious disease threats.